Seth Winterton
Family Medicine · Sanford, FLNPI 1093195331
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,661 and has fallen 89.8% since, to $170 in 2025.
Across 186 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$596
- AbbVie$385
- GSK$307
- Astellas Pharma US Inc$253
- Idorsia Pharmaceuticals US Inc$192
- AstraZeneca$178
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 38 | $596 |
| AbbVie | 23 | $385 |
| GSK | 12 | $307 |
| Astellas Pharma US Inc | 10 | $253 |
| Idorsia Pharmaceuticals US Inc | 12 | $192 |
| AstraZeneca | 12 | $178 |
| Boehringer Ingelheim | 9 | $171 |
| Dexcom, Inc. | 4 | $170 |
| Lilly USA, LLC | 10 | $167 |
| Medtronic | 1 | $125 |
| Amgen | 8 | $110 |
| Novartis | 6 | $93 |
| Sanofi-aventis U.S. LLC | 4 | $85 |
| Exact Sciences | 5 | $80 |
| Smith+Nephew | 3 | $71 |
| Abbott | 4 | $68 |
| Pfizer | 5 | $62 |
| Bayer | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Phadia US Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Millicent US Inc | 1 | $23 |
| Merck | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,439 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fludrocortisone Acetate | 11 | $240 |
| Levothyroxine Sodium | 14 | $218 |
| Tamsulosin Hcl | 12 | $206 |
| Metformin Hcl ErMetformin Hcl | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Sanford
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.